Navigation
Content
Footer
Global
Novartis site directory
Navigate Novartis
Patients & Caregivers
Healthcare Professionals
Media
Investors
Search
Our Company
Our Leadership
Board of Directors
Executive Committee of Novartis
Our Approach
Our Strategy
Our Culture and Values
Diversity & Inclusion
Our Stories
Novartis Portfolio
Global Product Portfolio
Global Clinical Pipeline
Media
All Novartis News
Media Contacts
Novartis Media Library
Stay Up-To-Date
Investors
Event Calendar
Financial Data
Share Data & Analysis
Shareholder Information
Corporate Responsibility
Corporate Responsibility at Novartis
Expanding Access to Healthcare
Ethics, Risk and Compliance
Our Business
Novartis Oncology
Novartis Pharmaceuticals
Alcon
Sandoz
Our Focus
Disease Areas
Cancer
Cardio-Metabolic
Immunology & Dermatology
Ophthalmology
Neuroscience
Respiratory
Navigate Novartis
Patients & Caregivers
Healthcare Professionals
Media
Investors
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
Our Science
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
Research & Early Development
Novartis Institutes for BioMedical Research
Research Disease Areas
Postdoc Program
Open Source Science
Drug Development at Novartis
Global Clinical Pipeline
Novartis Clinical Trials
Translational Medicine
Join Us
Your Career
Novartis Career Search
Careers in Research
Working at Novartis
Corporate Responsibility
Diversity & Inclusion
Our Culture and Values
Academic Programs
Students & Scholars
The STEP Program
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
Cancer Research Institute
View All Stories
Patient Perspectives
Choosing the right care
Discovery
Saving tumor suppressors from the shredder
Discovery
Eyewitness to a healer pursues new treatments for patients
Discovery
Reaping cancer clues from the blood
Discovery
Talking to: Bruno Strigini on why we're entering a transformative time in cancer care
Contains Video
Discovery
How scientists aim to expand immunotherapy options for cancer patients
From Our Labs
CRISPR genome editing fuels cancer drug discovery
Discovery
Intractable tumor cells crippled
Contains Video
Discovery
Novartis cancer researchers advance precision medicine
From Our Labs
Cancer spies find drug-beating covert cells
Pages
1
2
next ›
last »
